Did InvAscent beat the benchmark in exit from four-year-old pharma bet?

Healthcare-focussed private equity firm InvAscent, which is raising its fourth fund and has struck three new deals from the vehicle over the past nine months, has fully exited a four-year-old investment through a secondaries transaction.  The PE firm crossed the halfway mark in June for its fourth fund that aims to ......